Capture

PRODUCTS

  • From product development to translation into clinical trials, GTx’s clinically validated scalable electroporation technology is equipped to handle your most complex cellular engineering demands.

    • Rapidly transfect from 75 thousand to 20 billion cells
    • Move forward with 21 CFR Part 11 enabled software
    • Develop quickly with an established regulatory path supported by a FDA Master File
    • Manufacture confidently with closed, cGMP-compliant, ISO-certified and CE-marked products
    • Enjoy MaxCyte’s proprietary Flow Electroporation® technology
  • SMALL MOLECULE SYNTHESIS, FROM PRECLINICAL TO COMMERCIAL QUANTITIES

    With Millipore® CTDMO Services we support small molecule API synthesis projects from milligram to commercial quantities. We are the partner to address the most difficult challenges, whether the target is difficult to handle, synthesize, or source. With a true consultative and partnered approach, our services reduce complexity and minimize program risk in a cost-effective manner.

  • Pharmaceutical labeling and kitting are critical for ensuring drug safety, compliance, and efficiency. Explore advanced technology and regulatory adherence to streamline these processes.

  • Unleash the potential in your cell therapy with scalable, single-use bioreactors from 0.1L to 80L, empowering scientists to develop cell therapy products that combat cancer, diabetes, and heart failure. 

  • Mycenax develops and establishes high-quality cell lines for various host cell and product types. We are the experts for all cell line development activities, from vector construction to generating cell banks for GMP manufacturing following ICH and global regulatory requirements. We also support early-stage material generation for proof-of-concept studies or preclinical development programs.

WHITE PAPERS AND CASE STUDIES

NEWS